HM06514 | FNDC5 | muscle | MESH:D001932 | Brain Neoplasms | brain |
HM06514 | FNDC5 | muscle | MESH:D009401 | Nephrosis | kidney |
HM06514 | FNDC5 | muscle | MESH:D007333 | Insulin Resistance | |
HM06514 | FNDC5 | muscle | MESH:D010051 | Ovarian Neoplasms | uterus |
HM06514 | FNDC5 | muscle | MESH:D010051 | Ovarian Neoplasms | |
HM06514 | FNDC5 | muscle | MESH:D006331 | Heart Diseases | heart |
HM06514 | FNDC5 | muscle | MESH:D008114 | Liver Neoplasms, Experimental | |
HM06514 | FNDC5 | muscle | MESH:D009203 | Myocardial Infarction | heart |
HM06514 | FNDC5 | muscle | MESH:D012878 | Skin Neoplasms | |
HM06514 | FNDC5 | muscle | MESH:D001943 | Breast Neoplasms | breast |
HM06514 | FNDC5 | muscle | MESH:D005355 | Fibrosis | |
HM06514 | FNDC5 | muscle | MESH:D005909 | Glioblastoma | bone |
HM06514 | FNDC5 | muscle | MESH:D005909 | Glioblastoma | brain |
HM06514 | FNDC5 | muscle | MESH:D005909 | Glioblastoma | bone |
HM06514 | FNDC5 | muscle | MESH:D007674 | Kidney Diseases | ureter |
HM06514 | FNDC5 | muscle | MESH:D007674 | Kidney Diseases | pituitary |
HM06514 | FNDC5 | muscle | MESH:D007674 | Kidney Diseases | kidney |
HM06514 | FNDC5 | muscle | MESH:D006333 | Heart Failure | heart |
HM06514 | FNDC5 | muscle | MESH:D004714 | Endometrial Hyperplasia | |
HM06514 | FNDC5 | muscle | MESH:D008175 | Lung Neoplasms | lung |
HM06514 | FNDC5 | muscle | MESH:D015663 | Osteoporosis, Postmenopausal | |
HM06514 | FNDC5 | muscle | MESH:D008228 | Lymphoma, Non-Hodgkin | |
HM06514 | FNDC5 | muscle | MESH:D009421 | Nervous System Malformations | |
HM06514 | FNDC5 | muscle | MESH:D012512 | Sarcoma, Ewing's | |
HM06514 | FNDC5 | muscle | MESH:D012514 | Sarcoma, Kaposi | |
HM06514 | FNDC5 | muscle | MESH:D007676 | Kidney Failure, Chronic | kidney |
HM06514 | FNDC5 | muscle | MESH:D009202 | Cardiomyopathies | |
HM06514 | FNDC5 | muscle | MESH:D016889 | Endometrial Neoplasms | uterus |
HM06514 | FNDC5 | muscle | MESH:D002292 | Carcinoma, Renal Cell | kidney |
HM06514 | FNDC5 | muscle | MESH:D003924 | Diabetes Mellitus, Type 2 | pancreas |
HM06514 | FNDC5 | muscle | MESH:D006394 | Hemangiosarcoma | thyroid |
HM06514 | FNDC5 | muscle | MESH:D006394 | Hemangiosarcoma | spleen |
HM06514 | FNDC5 | muscle | MESH:D006394 | Hemangiosarcoma | prostate |
HM06514 | FNDC5 | muscle | MESH:D006394 | Hemangiosarcoma | liver |
HM06514 | FNDC5 | muscle | MESH:D006394 | Hemangiosarcoma | bone |
HM06514 | FNDC5 | muscle | MESH:D006394 | Hemangiosarcoma | blood vessel |
HM06514 | FNDC5 | muscle | MESH:D028361 | Mitochondrial Diseases | spinal cord |
HM06514 | FNDC5 | muscle | MESH:D028361 | Mitochondrial Diseases | muscle |
HM06514 | FNDC5 | muscle | MESH:D002318 | Cardiovascular Diseases | heart |
HM06514 | FNDC5 | muscle | MESH:D002318 | Cardiovascular Diseases | bone marrow |
HM06514 | FNDC5 | muscle | MESH:D002318 | Cardiovascular Diseases | blood vessel |
HM06514 | FNDC5 | muscle | MESH:D015179 | Colorectal Neoplasms | |
HM06514 | FNDC5 | muscle | MESH:D018222 | Fibromatosis, Aggressive | |
HM06514 | FNDC5 | muscle | MESH:D009362 | Neoplasm Metastasis | |
HM06514 | FNDC5 | muscle | MESH:D011471 | Prostatic Neoplasms | prostate |
HM06514 | FNDC5 | muscle | MESH:D010997 | Pleural Neoplasms | bone |
HM06514 | FNDC5 | muscle | MESH:D008545 | Melanoma | eye |
HM06514 | FNDC5 | muscle | MESH:D008545 | Melanoma | cervix |
HM06514 | FNDC5 | muscle | MESH:D008545 | Melanoma | bone |
HM06514 | FNDC5 | muscle | MESH:D013964 | Thyroid Neoplasms | thyroid |
HM06514 | FNDC5 | muscle | MESH:D008106 | Liver Cirrhosis, Experimental | |
HM06514 | FNDC5 | muscle | MESH:D003110 | Colonic Neoplasms | colon |
HM06514 | FNDC5 | muscle | MESH:D051437 | Renal Insufficiency | |
HM06514 | FNDC5 | muscle | MESH:D002276 | Carcinoid Tumor | |
HM06514 | FNDC5 | muscle | MESH:D001161 | Arteriosclerosis | blood vessel |
HM06514 | FNDC5 | muscle | MESH:D012983 | Soft Tissue Neoplasms | muscle |
HM06514 | FNDC5 | muscle | MESH:D012983 | Soft Tissue Neoplasms | cervix |
HM06514 | FNDC5 | muscle | MESH:D012983 | Soft Tissue Neoplasms | bone |
HM06514 | FNDC5 | muscle | MESH:D016399 | Lymphoma, T-Cell | |
HM06514 | FNDC5 | muscle | MESH:D015428 | Myocardial Reperfusion Injury | |
HM06514 | FNDC5 | muscle | MESH:D056486 | Drug-Induced Liver Injury | |
HM06514 | FNDC5 | muscle | MESH:D008103 | Liver Cirrhosis | liver |
HM06514 | FNDC5 | muscle | MESH:D008223 | Lymphoma | |
HM06514 | FNDC5 | muscle | MESH:D012509 | Sarcoma | |
HM06514 | FNDC5 | muscle | MESH:D012509 | Sarcoma | |
HM06514 | FNDC5 | muscle | MESH:D001749 | Urinary Bladder Neoplasms | ureter |
HM06514 | FNDC5 | muscle | MESH:D001749 | Urinary Bladder Neoplasms | bladder |
HM06514 | FNDC5 | muscle | MESH:D004362 | Drug Toxicity | |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | uterus |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | uterus |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | thyroid |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | skin |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | parathyroid gland |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | liver |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | kidney |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | eye |
HM06514 | FNDC5 | muscle | MESH:D000230 | Adenocarcinoma | adrenal gland |
HM06514 | FNDC5 | muscle | MESH:D010024 | Osteoporosis | bone |
HM06514 | FNDC5 | muscle | MESH:D018487 | Ventricular Dysfunction, Left | |
HM06514 | FNDC5 | muscle | MESH:D002294 | Carcinoma, Squamous Cell | lung |
HM06514 | FNDC5 | muscle | MESH:D002294 | Carcinoma, Squamous Cell | liver |
HM06514 | FNDC5 | muscle | MESH:D002294 | Carcinoma, Squamous Cell | larynx |
HM06514 | FNDC5 | muscle | MESH:D002294 | Carcinoma, Squamous Cell | kidney |
HM06514 | FNDC5 | muscle | MESH:D002294 | Carcinoma, Squamous Cell | eye |
HM06514 | FNDC5 | muscle | MESH:D005234 | Fatty Liver | |
HM06514 | FNDC5 | muscle | MESH:D006689 | Hodgkin Disease | |
HM06514 | FNDC5 | muscle | MESH:D003557 | Phyllodes Tumor | prostate |
HM06514 | FNDC5 | muscle | MESH:D003557 | Phyllodes Tumor | bone |
HM06514 | FNDC5 | muscle | MESH:D003557 | Phyllodes Tumor | prostate |
HM06514 | FNDC5 | muscle | MESH:D003557 | Phyllodes Tumor | bone |
HM06514 | FNDC5 | muscle | MESH:D002311 | Cardiomyopathy, Dilated | heart |
HM06514 | FNDC5 | muscle | MESH:D050171 | Dyslipidemias | |
HM06514 | FNDC5 | muscle | MESH:D006258 | Head and Neck Neoplasms | thyroid |
HM06514 | FNDC5 | muscle | MESH:D006258 | Head and Neck Neoplasms | skin |
HM06514 | FNDC5 | muscle | MESH:D006258 | Head and Neck Neoplasms | parathyroid gland |
HM06514 | FNDC5 | muscle | MESH:D006258 | Head and Neck Neoplasms | larynx |
HM06514 | FNDC5 | muscle | MESH:D006258 | Head and Neck Neoplasms | ear |
HM06514 | FNDC5 | muscle | MESH:D006258 | Head and Neck Neoplasms | brain |
HM06514 | FNDC5 | muscle | MESH:D052016 | Mucositis | |
HM06514 | FNDC5 | muscle | MESH:D007249 | Inflammation | |
HM06514 | FNDC5 | muscle | MESH:D004915 | Leukemia, Erythroblastic, Acute | |
HM06514 | FNDC5 | muscle | MESH:D009447 | Neuroblastoma | eye |
HM06514 | FNDC5 | muscle | MESH:D009447 | Neuroblastoma | brain |
HM06514 | FNDC5 | muscle | MESH:D007938 | Leukemia | spleen |
HM06514 | FNDC5 | muscle | MESH:D007938 | Leukemia | bone marrow |
HM06514 | FNDC5 | muscle | MESH:D012516 | Osteosarcoma | muscle |
HM06514 | FNDC5 | muscle | MESH:D012516 | Osteosarcoma | bone |
HM06514 | FNDC5 | muscle | MESH:D008325 | Mammary Neoplasms, Experimental | |
HM06514 | FNDC5 | muscle | MESH:D009404 | Nephrotic Syndrome | kidney |
HM06514 | FNDC5 | muscle | MESH:D006528 | Carcinoma, Hepatocellular | liver |
HM06514 | FNDC5 | muscle | MESH:D008654 | Mesothelioma | bone |
HM06514 | FNDC5 | muscle | MESH:D009765 | Obesity | |
HM06514 | FNDC5 | muscle | MESH:D019046 | Bone Marrow Neoplasms | |
HM06514 | FNDC5 | muscle | MESH:D004719 | Endomyocardial Fibrosis | heart |